Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney
- 1 September 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 83 (3-4), 243-252
- https://doi.org/10.1016/0014-2999(82)90257-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.Hypertension, 1981
- Role of Prostaglandin in the Antihypertensive Mechanism of Captopril in Low Renin HypertensionClinical Science, 1980
- Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney [letter]British Journal of Clinical Pharmacology, 1980
- Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brainEuropean Journal of Pharmacology, 1980
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- The kininsBiochemical Pharmacology, 1976
- Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolismNature, 1976
- Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human PlasmaEuropean Journal of Clinical Investigation, 1975